Catalyst Wire Dossier Catalyst Wire Dossier

JE-CV (Chimeric Japanese Encephalitis Vaccine)

Chimeric Japanese encephalitis vaccine · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JE-CV (Chimeric Japanese Encephalitis Vaccine), covering 2017-11-29 to 2017-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers [Phase 3]

See pricing